News

Ocugen co-founder and CEO Shankar Musunuri, Ph.D. explains what biotech leaders can learn from the Philadelphia Eagles, an agile team with a championship mindset.
Nuclear hormone receptors. Nuclear hormone receptors, specifically the androgen receptor (AR), are modulated in their transcriptional activity by actin and ABPs, in addition to being under the ...
A tiny gene variant found in skeletal muscle cells appears to have powerful-yet-opposing effects on health for men and women, ...
Denosumab is a human monoclonal antibody that targets and binds a protein known as RANKL (Receptor Activator of Nuclear Factor Kappa-B Ligand).
Biocon Biologics’ Denosumab biosimilars, Vevzuo and Evfraxy, have received marketing authorisation in the European Union (EU).
Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd., today announced that ...
Bengaluru: Biocon Biologics Ltd, a fully integrated global biosimilars company and subsidiary of Biocon Ltd., has announced ...
Common isotopes include lutetium-177, actinium-225, gallium-68 (diagnostic), fluorine-18, and radium-223. The therapy combines isotopic radiance with molecular targeting-e.g., PSMA in prostate cancer ...
Recruitment initiated into the Phase 2 opaganib plus darolutamide study in patients with advanced prostate cancer, sponsored ...
Turmeric and ginger are antioxidant powerhouses—but which is stronger? Discover benefits, side effects, and whether you can ...
Postpartum depression (PPD) affects a significantly higher percentage of Indian mothers compared to the global average. This ...
Denosumab is a human monoclonal antibody that targets and binds a protein known as RANKL (Receptor Activator of Nuclear ...